Condition: Aortic Valve Stenosis · Sponsor: St. Antonius Hospital
A multicentre cross-sectional cohort study to assess the difference in bioprosthetic micro-calcification activity, detected with 18F-NaF PET-CT, as early marker of transcatheter valve degeneration, between patients with vs. without subclinical leaflet thrombosis at five years after TAVI; and between patients with intra-annular vs. supra-annular TAVI prostheses.
This description comes directly from the study's public registry record.
Dirk-Jan van Ginkel, MD · +31 (0)88 320 66 48 · d.van.ginkel@antoniusziekenhuis.nl
Prof. J.M. ten Berg, MD, PhD, MSc · jurtenberg@gmail.com
Always discuss trial participation with your own doctor first.
| Rigshospitalet | Copenhagen, Denmark | Recruiting |
| St. Antonius Hospital | Nieuwegein, Utrecht, Netherlands | Recruiting |
| Amsterdam UMC | Amsterdam, Netherlands | Recruiting |
| University of Edinburgh | Edinburgh, United Kingdom | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05758662